CLOZAPINE Side Effects

6922572-5 | Asthenia, Dry Skin, Hepatic Steatosis, Hepatomegaly, Hepatosplenomegaly, Micturition Urgency, Pallor, Pancreatitis, Thirst
on Jul 30, 2010 Female patient from GERMANY , 46 years of age, weighting 183.0 lb, was diagnosed with schizophrenia and was treated with Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, dry skin, hepatic steatosis, hepatomegaly, hepatosplenomegaly, micturition urgency, pallor, pancreatitis, thirst. Clozapine dosage: Unk. During the same period patient was treated with ZELDOX (Unk) (View Zeldox Review and Zeldox Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized and became disabled.

6913985-6 | Asthenia, Blood Creatine Phosphokinase Increased, Bone Pain, C-reactive Protein Increased, Electrocardiogram T Wave Inversion, Fatigue, Myositis, Sinus Tachycardia
Patient was taking Clozapine (View Usage). Patient had the following side effects: asthenia, blood creatine phosphokinase increased, bone pain, c-reactive protein increased, electrocardiogram t wave inversion, fatigue, myositis (What is myositis?), sinus tachycardia on Jul 26, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 27 years of age, was diagnosed with schizophrenia and. Clozapine dosage: 200 Mg, Unk. Patient was hospitalized.

6913976-5 | Arthralgia, Body Temperature Increased, Chills, Headache, Influenza Like Illness, Leukocytosis, Myalgia, Myoglobin Blood Increased
Adverse event was reported on Jul 25, 2010 by a Male patient taking Clozapine (View Usage) (Dosage: Unk) was diagnosed with schizophrenia, paranoid type and. Location: UNITED STATES , 37 years of age, After Clozapine was administered, patient had the following side effects: arthralgia, body temperature increased, chills, headache (What is headache?), influenza like illness, leukocytosis, myalgia, myoglobin blood increased. During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), DISULFIRAM (View Disulfiram Review and Disulfiram Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), CLOMIPRAMINE (View Clomipramine Review and Clomipramine Label ).

6910488-X | Acute Pulmonary Oedema, Epilepsy
on Jul 22, 2010 Male patient from UNITED KINGDOM , 26 years of age, weighting 220.5 lb, was treated with Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: acute pulmonary oedema, epilepsy (What is epilepsy?). Clozapine dosage: Unk. During the same period patient was treated with ZAPONEX (Unk) (View Zaponex Review and Zaponex Label ), LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ), MINOCYCLINE HCL (View Minocycline Hcl Review and Minocycline Hcl Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).


6909728-2 | Convulsion, Drooling, Extrapyramidal Disorder, Pleural Effusion, Sedation, Weight Decreased, Weight Increased
on Jul 23, 2010 Male patient from UNITED STATES , 36 years of age, was diagnosed with schizophrenia, epilepsy (What is epilepsy?) and was treated with Clozapine (View Usage). Patient had the following side effects: convulsion, drooling, extrapyramidal disorder, pleural effusion, sedation, weight decreased, weight increased. Clozapine dosage: . During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ), COGENTIN (View Cogentin Review and Cogentin Label ).

6906871-9 | Hepatitis C, Leukopenia, Neutropenia
Patient was taking Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: hepatitis c (What is hepatitis c?), leukopenia, neutropenia on Jul 05, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 47 years of age, . Clozapine dosage: Unk. During the same period patient was treated with ZAPONEX (Unk) (View Zaponex Review and Zaponex Label ).

6901012-6 | Convulsion, Fall
Adverse event was reported on Jul 26, 2010 by a Female patient taking Clozapine (View Usage) (Dosage: ) was diagnosed with schizophrenia and. Location: UNITED STATES , 71 years of age, weighting 230.0 lb, Patient experienced the following unwanted or unexpected effects: convulsion, fall (What is fall?). During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ).

6888508-0 | Activities Of Daily Living Impaired, Blood Alkaline Phosphatase Increased, Blood Triglycerides Increased, Fatigue, Hepatic Steatosis, Sleep Apnoea Syndrome, Vitamin D Decreased, Weight Increased
on Jul 19, 2010 Female patient from AUSTRALIA , 23 years of age, was diagnosed with schizophrenia and was treated with Clozapine (View Usage). Patient had the following side effects: activities of daily living impaired, blood alkaline phosphatase increased, blood triglycerides increased, fatigue, hepatic steatosis, sleep apnoea syndrome, vitamin d decreased, weight increased. Clozapine dosage: 600 Mg, Qd.

6887804-0 | Abdominal Pain, Cachexia, Coagulopathy, Colitis Ischaemic, Constipation, Delirium, Diarrhoea, Diarrhoea Haemorrhagic, Discomfort
on Jul 16, 2010 Male patient from SPAIN , 34 years of age, was diagnosed with schizophrenia, paranoid type and was treated with Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), cachexia, coagulopathy, colitis ischaemic, constipation (What is constipation?), delirium, diarrhoea, diarrhoea haemorrhagic, discomfort. Clozapine dosage: 200 Mg, Qd. Patient was hospitalized.

6881378-6 | Dilatation Ventricular, Myocarditis
Patient was taking Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: dilatation ventricular, myocarditis on Jul 28, 2010 from SAUDI ARABIA Additional patient health information: Female patient , weighting 143.3 lb, was diagnosed with psychotic disorder (What is psychotic disorder?) and. Clozapine dosage: 25 Once Daily Po.

6880020-8 | Circulatory Collapse, Non-small Cell Lung Cancer Metastatic
Adverse event was reported on Jul 23, 2010 by a Male patient taking Clozapine (View Usage) (Dosage: Unk) . Location: UNITED KINGDOM , 59 years of age, Patient had the following side effects: circulatory collapse, non-small cell lung cancer metastatic. During the same period patient was treated with ZAPONEX (600mg) (View Zaponex Review and Zaponex Label ).

6877948-1 | Hyperlipidaemia
on Jul 22, 2010 Female patient from UNITED KINGDOM , 32 years of age, weighting 216.1 lb, was diagnosed with schizophrenia and was treated with Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: hyperlipidaemia. Clozapine dosage: 450 Mg Daily.

6877938-9 | Cardiac Hypertrophy, Sleep Apnoea Syndrome, Weight Increased
on Jul 22, 2010 Male patient from UNITED KINGDOM , 34 years of age, was treated with Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac hypertrophy, sleep apnoea syndrome, weight increased. Clozapine dosage: Unk. During the same period patient was treated with ZAPONEX (Unk) (View Zaponex Review and Zaponex Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ).

6870858-5 | Autonomic Nervous System Imbalance, Catatonia, Withdrawal Syndrome
Patient was taking Clozapine (View Usage). Patient had the following side effects: autonomic nervous system imbalance, catatonia, withdrawal syndrome on Jul 12, 2010 from UNITED STATES Additional patient health information: Female patient , 49 years of age, . Clozapine dosage: .

6865936-0 | Mental Status Changes, Psychotic Disorder
Adverse event was reported on Jul 19, 2010 by a Male patient taking Clozapine (View Usage) (Dosage: ) . Location: CANADA , 21 years of age, After Clozapine was administered, patient had the following side effects: mental status changes, psychotic disorder (What is psychotic disorder?). During the same period patient was treated with ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ).

6860742-5 | Cerebral Venous Thrombosis, Convulsion, Fatigue, Hemiparesis, Impaired Self-care, Irritability, Vomiting
on Jul 12, 2010 Female patient from INDIA , 30 years of age, was diagnosed with schizophrenia, paranoid type and was treated with Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral venous thrombosis, convulsion, fatigue, hemiparesis, impaired self-care, irritability, vomiting. Clozapine dosage: 400 Mg, Unk. Patient was hospitalized.

6860226-4 | Agitation, Altered State Of Consciousness, Blood Creatine Phosphokinase Increased, Confusional State, Delirium, Diet Refusal, Flushing, Hyperhidrosis
on Jul 06, 2010 Male patient from HONG KONG , 42 years of age, was diagnosed with schizophrenia and was treated with Clozapine (View Usage). Patient had the following side effects: agitation, altered state of consciousness, blood creatine phosphokinase increased, confusional state, delirium, diet refusal, flushing, hyperhidrosis. Clozapine dosage: 500 Mg, Qd (50mg At 5pm And 450mg At 8pm). During the same period patient was treated with ANTISEPTICS AND DISINFECTANTS (View Antiseptics And Disinfectants Review and Antiseptics And Disinfectants Label ). Patient was hospitalized.

6843783-3 | Blood Creatine Phosphokinase Increased, Blood Creatine Phosphokinase Mb Increased, Cardiomegaly, Crepitations, Dyspnoea, Ejection Fraction Decreased, Electrocardiogram St Segment Elevation, Hyperhidrosis, Hypotension
Patient was taking Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, cardiomegaly, crepitations, dyspnoea, ejection fraction decreased, electrocardiogram st segment elevation, hyperhidrosis, hypotension on Jun 30, 2010 from IRELAND Additional patient health information: Male patient , 26 years of age, . Clozapine dosage: .

6840341-1 | Ileus, Pneumatosis Intestinalis, Psychotic Disorder
Adverse event was reported on Jul 13, 2010 by a Male patient taking Clozapine (View Usage) (Dosage: 400 Mg Daily Po) was diagnosed with schizophrenia, paranoid type and. Location: UNITED STATES , 60 years of age, weighting 199.1 lb, Patient experienced the following unwanted or unexpected effects: ileus, pneumatosis intestinalis, psychotic disorder (What is psychotic disorder?). During the same period patient was treated with CHLORPROMAZINE (200 Mg Hs Po) (View Chlorpromazine Review and Chlorpromazine Label ). Patient was hospitalized.

6836280-2 | Nausea, Neutropenia
on Jul 12, 2010 Female patient from UNITED STATES , weighting 211.6 lb, was treated with Clozapine (View Usage). Patient had the following side effects: nausea (What is nausea?), neutropenia. Clozapine dosage: 75 Mg (3 Tabs) Daily Oral. Patient was hospitalized.

6826298-8 | Tooth Abscess
on Jun 29, 2010 Male patient from UNITED KINGDOM , 56 years of age, was diagnosed with blood cholesterol increased and was treated with Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: tooth abscess. Clozapine dosage: Unk. During the same period patient was treated with ZAPONEX (100mg Mane And 200mg Nocte) (View Zaponex Review and Zaponex Label ), ACTOS (40mg/day) (View Actos Review and Actos Label ), ATORVASTATIN (40 Mg, Qd) (View Atorvastatin Review and Atorvastatin Label ), ESOMEPRAZOLE MAGNESIUM (40mg/day) (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), EZETROL (10 Mg, Qd) (View Ezetrol Review and Ezetrol Label ), FERROUS SULFATE TAB (400 Mg, Qd) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FLUOXETINE (40 Mg, Qd) (View Fluoxetine Review and Fluoxetine Label ), ORPHENADRINE CITRATE (100 Mg, Qd) (View Orphenadrine Citrate Review and Orphenadrine Citrate Label ).

6826257-5 | Anaphylactic Reaction, Hypotension, Mean Arterial Pressure Decreased, Pulmonary Mass
Patient was taking Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, hypotension, mean arterial pressure decreased, pulmonary mass on Jun 28, 2010 from UNITED STATES Additional patient health information: Male patient , 48 years of age, weighting 158.7 lb, . Clozapine dosage: 700 Mg, Qd (200 Mg Every Morning And 500 Mg Every Evening). During the same period patient was treated with BENZTROPINE MESYLATE (View Benztropine Mesylate Review and Benztropine Mesylate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MIDAZOLAM HCL (2 Mg, Unk) (View Midazolam Hcl Review and Midazolam Hcl Label ), PROPOFOL (200 Mg, Unk) (View Propofol Review and Propofol Label ), LIDOCAINE (50 Mg, Unk) (View Lidocaine Review and Lidocaine Label ), FENTANYL (100 Ug, Unk) (View Fentanyl Review and Fentanyl Label ), SUCCINYLCHOLINE CHLORIDE (View Succinylcholine Chloride Review and Succinylcholine Chloride Label ), SEVOFLURANE (1.2%-1.5%) (View Sevoflurane Review and Sevoflurane Label ).

6817988-1 | Agitation, Confusional State, Delirium, Flushing, Hyperhidrosis, Restlessness, Salivary Hypersecretion
Adverse event was reported on Jun 24, 2010 by a Male patient taking Clozapine (View Usage) (Dosage: 50 Mg At 5pm And 450mg At 8pm) was diagnosed with schizophrenia and. Location: HONG KONG , 42 years of age, Patient had the following side effects: agitation, confusional state, delirium, flushing, hyperhidrosis, restlessness, salivary hypersecretion. Patient was hospitalized.

6816977-0 | Autonomic Nervous System Imbalance, Catatonia, Dyskinesia, Neuroleptic Malignant Syndrome, Psychotic Disorder
on Jun 23, 2010 Male patient from MALAYSIA , 30 years of age, was treated with Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: autonomic nervous system imbalance, catatonia, dyskinesia, neuroleptic malignant syndrome, psychotic disorder (What is psychotic disorder?). Clozapine dosage: Unk.

6816726-6 | Concomitant Disease Progression, Mental Impairment, Obsessive-compulsive Disorder, Psychotic Disorder
on Jun 22, 2010 Male patient from CANADA , 21 years of age, was diagnosed with schizophrenia and was treated with Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: concomitant disease progression, mental impairment, obsessive-compulsive disorder (What is obsessive-compulsive disorder?), psychotic disorder (What is psychotic disorder?). Clozapine dosage: 275 Mg/day. During the same period patient was treated with ARIPIPRAZOLE (10 Mg/day) (View Aripiprazole Review and Aripiprazole Label ).

6816613-3 | Mental Status Changes, Obsessive-compulsive Disorder, Psychotic Disorder
Patient was taking Clozapine (View Usage). Patient had the following side effects: mental status changes, obsessive-compulsive disorder (What is obsessive-compulsive disorder?), psychotic disorder (What is psychotic disorder?) on Jun 21, 2010 from CANADA Additional patient health information: Male patient , 21 years of age, was diagnosed with schizophrenia and. Clozapine dosage: . During the same period patient was treated with ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ).

6814456-8 | Heart Rate Increased, Hyperhidrosis, Influenza Like Illness, Myocarditis, Neutrophil Count Increased, White Blood Cell Count Increased
Adverse event was reported on Jun 21, 2010 by a Male patient taking Clozapine (View Usage) (Dosage: 175 Mg, Unk) was diagnosed with schizophrenia and. Location: UNITED KINGDOM , 33 years of age, After Clozapine was administered, patient had the following side effects: heart rate increased, hyperhidrosis, influenza like illness, myocarditis, neutrophil count increased, white blood cell count increased. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6814078-9 | Cardiac Hypertrophy, Sleep Apnoea Syndrome, Weight Increased
on Jun 28, 2010 Male patient from UNITED KINGDOM , 34 years of age, was treated with Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac hypertrophy, sleep apnoea syndrome, weight increased. Clozapine dosage: Unk. During the same period patient was treated with ZAPONEX (Unk) (View Zaponex Review and Zaponex Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ).

6814055-8 | Acute Pulmonary Oedema, Epilepsy
on Jun 23, 2010 Female patient from UNITED KINGDOM , weighting 220.5 lb, was treated with Clozapine (View Usage). Patient had the following side effects: acute pulmonary oedema, epilepsy (What is epilepsy?). Clozapine dosage: Unk. During the same period patient was treated with ZAPONEX (Unk) (View Zaponex Review and Zaponex Label ), LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ), MINOCYCLINE (View Minocycline Review and Minocycline Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

6814052-2 | Dyspnoea, Intestinal Obstruction, Pneumonia Aspiration, Volvulus, Vomiting
Patient was taking Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: dyspnoea, intestinal obstruction, pneumonia aspiration, volvulus, vomiting on Jun 23, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 143.3 lb, . Clozapine dosage: Unk. During the same period patient was treated with ZAPONEX (Unk) (View Zaponex Review and Zaponex Label ). Patient was hospitalized.

6813531-1 | Mental Status Changes, Psychotic Disorder
Adverse event was reported on Jun 21, 2010 by a Male patient taking Clozapine (View Usage) (Dosage: ) . Location: CANADA , 21 years of age, Patient experienced the following unwanted or unexpected effects: mental status changes, psychotic disorder (What is psychotic disorder?). During the same period patient was treated with ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ).

6812919-2 | Catatonia, Neuroleptic Malignant Syndrome, Withdrawal Syndrome
on Jun 21, 2010 Male patient from MALAYSIA , 30 years of age, was treated with Clozapine (View Usage). Patient had the following side effects: catatonia, neuroleptic malignant syndrome, withdrawal syndrome. Clozapine dosage: .

6809574-4 | Blood Lactate Dehydrogenase Increased, Blood Urea Increased, Brain Natriuretic Peptide Increased, C-reactive Protein Increased, Gamma-glutamyltransferase Increased
on Jun 24, 2010 Female patient from GERMANY , 78 years of age, weighting 198.4 lb, was diagnosed with psychotic disorder (What is psychotic disorder?), parkinson's disease (What is parkinson's disease?) and was treated with Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: blood lactate dehydrogenase increased, blood urea increased, brain natriuretic peptide increased, c-reactive protein increased, gamma-glutamyltransferase increased. Clozapine dosage: 25 Mg, Qd. During the same period patient was treated with NACOM (1000 Mg, Qd) (View Nacom Review and Nacom Label ), CELEBREX (200 Mg) (View Celebrex Review and Celebrex Label ), ENALAPRIL MALEATE (5 Mg, Qd) (View Enalapril Maleate Review and Enalapril Maleate Label ), MCP (View Mcp Review and Mcp Label ).

6805792-X | Intentional Overdose, Lethargy, Suicide Attempt
Patient was taking Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: intentional overdose, lethargy, suicide attempt on Jun 14, 2010 from GERMANY Additional patient health information: Female patient , 82 years of age, was diagnosed with intentional overdose and. Clozapine dosage: . Patient was hospitalized.

6805791-8 | Intentional Overdose, Lethargy, Suicide Attempt
Adverse event was reported on Jun 14, 2010 by a Female patient taking Clozapine (View Usage) (Dosage: ) was diagnosed with intentional overdose and. Location: GERMANY , 82 years of age, Patient had the following side effects: intentional overdose, lethargy, suicide attempt. Patient was hospitalized.

6795780-4 | Autonomic Nervous System Imbalance, Catatonia, Dyskinesia, Psychotic Disorder, Withdrawal Syndrome
on Jun 16, 2010 Male patient from MALAYSIA , 30 years of age, was treated with Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: autonomic nervous system imbalance, catatonia, dyskinesia, psychotic disorder (What is psychotic disorder?), withdrawal syndrome. Clozapine dosage: Unk.

6793884-3 | Granulocytopenia
on Jun 14, 2010 Male patient from UNITED STATES , 34 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?) and was treated with Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: granulocytopenia. Clozapine dosage: . During the same period patient was treated with LITHIUM (View Lithium Review and Lithium Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

6793883-1 | Granulocytopenia, Leukopenia
Patient was taking Clozapine (View Usage). Patient had the following side effects: granulocytopenia, leukopenia on Mar 31, 2010 from UNITED STATES Additional patient health information: Female patient , 85 years of age, . Clozapine dosage: .

6793882-X | Granulocytopenia
Adverse event was reported on Jan 15, 2010 by a Male patient taking Clozapine (View Usage) (Dosage: ) . Location: UNITED STATES , 54 years of age, After Clozapine was administered, patient had the following side effects: granulocytopenia.

6793881-8 | Granulocytopenia
on Feb 22, 2010 Male patient from UNITED STATES , 51 years of age, was treated with Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: granulocytopenia. Clozapine dosage: . During the same period patient was treated with POTASSIUM (View Potassium Review and Potassium Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), PREVACID (View Prevacid Review and Prevacid Label ), DEPAKOTE (View Depakote Review and Depakote Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ).

6793880-6 | Granulocytopenia, Pneumonia
on Feb 17, 2010 Female patient from UNITED STATES , 38 years of age, was diagnosed with schizophrenia, blood cholesterol increased, type 2 diabetes mellitus, hypothyroidism, hypertension and was treated with Clozapine (View Usage). Patient had the following side effects: granulocytopenia, pneumonia (What is pneumonia?). Clozapine dosage: . During the same period patient was treated with DIVALPROEX SODIUM EXTENDED RELEASE (View Divalproex Sodium Extended Release Review and Divalproex Sodium Extended Release Label ), TRICOR (View Tricor Review and Tricor Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), FLUVOXAMINE MALEATE (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

6793879-X | Granulocytopenia, Leukopenia
Patient was taking Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: granulocytopenia, leukopenia on Feb 12, 2010 from UNITED STATES Additional patient health information: Female patient , 65 years of age, . Clozapine dosage: . During the same period patient was treated with LOPID (View Lopid Review and Lopid Label ), ZANTAC (View Zantac Review and Zantac Label ), DEPAKOTE (View Depakote Review and Depakote Label ), PROZAC (View Prozac Review and Prozac Label ), ARICEPT (View Aricept Review and Aricept Label ).

6793878-8 | Granulocytopenia, Leukopenia
Adverse event was reported on Dec 10, 2009 by a Male patient taking Clozapine (View Usage) (Dosage: ) was diagnosed with schizophrenia and. Location: UNITED STATES , 21 years of age, Patient experienced the following unwanted or unexpected effects: granulocytopenia, leukopenia. During the same period patient was treated with COGENTIN (View Cogentin Review and Cogentin Label ), DEPAKOTE (View Depakote Review and Depakote Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), KEPPRA (View Keppra Review and Keppra Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), PROLIXIN /00000602/ (View Prolixin /00000602/ Review and Prolixin /00000602/ Label ).

6793877-6 | Granulocytopenia
on Oct 20, 2009 Male patient from UNITED STATES , 16 years of age, was treated with Clozapine (View Usage). Patient had the following side effects: granulocytopenia. Clozapine dosage: . During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ), COGENTIN (View Cogentin Review and Cogentin Label ).

6793526-7 | Bipolar Disorder, Granulocytopenia, Leukopenia
on Jun 07, 2010 Male patient from UNITED STATES , 36 years of age, weighting 181.8 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: bipolar disorder (What is bipolar disorder?), granulocytopenia, leukopenia. Clozapine dosage: . During the same period patient was treated with ZYPREXA (View Zyprexa Review and Zyprexa Label ), DEPAKOTE (View Depakote Review and Depakote Label ), DESMOPRESSIN ACETATE (View Desmopressin Acetate Review and Desmopressin Acetate Label ), LOPID (View Lopid Review and Lopid Label ), NIASPAN (View Niaspan Review and Niaspan Label ).

6793525-5 | Agranulocytosis, Diabetic Ketoacidosis
Patient was taking Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, diabetic ketoacidosis on Jun 17, 2010 from UNITED STATES Additional patient health information: Female patient , 28 years of age, was diagnosed with schizoaffective disorder, psychotic disorder (What is psychotic disorder?) and. Clozapine dosage: . During the same period patient was treated with LANTUS /01483501/ (View Lantus /01483501/ Review and Lantus /01483501/ Label ), DEPAKOTE (View Depakote Review and Depakote Label ), LIPITOR (View Lipitor Review and Lipitor Label ), TOPAMAX (View Topamax Review and Topamax Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ). Patient was hospitalized.

6793524-3 | Agranulocytosis, Granulocytopenia, Leukopenia
Adverse event was reported on Jun 01, 2010 by a Female patient taking Clozapine (View Usage) (Dosage: ) was diagnosed with schizophrenia and. Location: UNITED STATES , 51 years of age, weighting 112.0 lb, Patient had the following side effects: agranulocytosis, granulocytopenia, leukopenia. During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), WELLBUTRIN XL (View Wellbutrin Xl Review and Wellbutrin Xl Label ), ZOLOFT (View Zoloft Review and Zoloft Label ).

6793522-X | Cardiac Failure
on Jun 01, 2010 Female patient from UNITED STATES , 61 years of age, was diagnosed with schizophrenia and was treated with Clozapine (View Usage). After Clozapine was administered, patient had the following side effects: cardiac failure. Clozapine dosage: .

6793521-8 | Granulocytopenia, Leukopenia
on Apr 30, 2010 Female patient from UNITED STATES , 41 years of age, was diagnosed with schizophrenia, paranoid type and was treated with Clozapine (View Usage). Patient experienced the following unwanted or unexpected effects: granulocytopenia, leukopenia. Clozapine dosage: .

6793520-6 | Granulocytopenia, Leukopenia
Patient was taking Clozapine (View Usage). Patient had the following side effects: granulocytopenia, leukopenia on Apr 30, 2010 from UNITED STATES Additional patient health information: Female patient , 48 years of age, was diagnosed with schizophrenia, hypertension, depression (What is depression?) and. Clozapine dosage: . During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), DESYREL (View Desyrel Review and Desyrel Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ), COPEGUS (View Copegus Review and Copegus Label ), HYDROXYCHLOROQUINE (View Hydroxychloroquine Review and Hydroxychloroquine Label ), SULAR (View Sular Review and Sular Label ).